Help

Powered by GGF
Home / NYT / Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

-

By GINA KOLATA from NYT Health https://ift.tt/2CQNI7l
via Transplants, Drugs (Pharmaceuticals) The New York Times https://ift.tt/2CQNI7l April 2, 2019 at 05:30AM
Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them? Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them? Reviewed by Imran Rk on April 02, 2019 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.